Eikon Therapeutics, Inc., is a clinical biopharmaceutical company in the United States. The company is headquartered in Millbrae, California. Show more

230 HARRIET TUBMAN WAY, MILLBRAE, CA, UNITED STATES, 94030, Millbrae, CA, 94030, USA

https://eikontx.com

BIOTECHNOLOGY

HEALTHCARE

Start AI Chat

Market Cap

498.6M

52 Wk Range

$7.90 - $17.40

Previous Close

$9.21

Open

$9.38

Volume

256,718

Day Range

$9.08 - $9.55

Enterprise Value

242.3M

Cash

161.6M

Avg Qtr Burn

-89.8M

Insider Ownership

17.39%

Institutional Own.

66.77%

Qtr Updated

03/31/26

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
EIK1001 Details Advanced melanoma	Phase 2/3 Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
EIK1001 Details Stage 4 NSCLC	Phase 2/3 Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
EIK1004 Details Solid tumors with and without brain metastases	Phase 1/2 Update	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
EIK1003 (Selective PARP1 Inhibitor) Details Metastatic Prostate Cancer	Phase 1/2 Update	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
EIK1003 Details Advanced solid tumor/s, Ovarian, breast, prostate, and pancreatic cancers	Phase 1/2 Update	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
EIK1005 Details MSI-high / dMMR advanced solid tumors	Phase 1/2 Update	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
EIK1006 Details Prostate cancer	IND Submission	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.